Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

Avai Bio (AVAI) Free Cash Flow (2018 - 2024)

Avai Bio's Free Cash Flow history spans 6 years, with the latest figure at -$136522.0 for Q1 2024.

  • For Q1 2024, Free Cash Flow fell 85.76% year-over-year to -$136522.0; the TTM value through Mar 2024 reached -$1.3 million, down 2328.19%, while the annual FY2025 figure was -$1.2 million, 12.23% up from the prior year.
  • Free Cash Flow for Q1 2024 was -$136522.0 at Avai Bio, up from -$705669.0 in the prior quarter.
  • Across five years, Free Cash Flow topped out at $109696.0 in Q1 2020 and bottomed at -$705669.0 in Q4 2023.
  • The 4-year median for Free Cash Flow is -$66609.5 (2023), against an average of -$117834.2.
  • The largest annual shift saw Free Cash Flow surged 3010.48% in 2020 before it plummeted 2265.56% in 2023.
  • A 4-year view of Free Cash Flow shows it stood at -$122550.0 in 2020, then skyrocketed by 126.59% to $32586.0 in 2022, then tumbled by 2265.56% to -$705669.0 in 2023, then skyrocketed by 80.65% to -$136522.0 in 2024.
  • Per Business Quant, the three most recent readings for AVAI's Free Cash Flow are -$136522.0 (Q1 2024), -$705669.0 (Q4 2023), and -$420401.0 (Q3 2023).